Cargando…
Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added (123)I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity
PURPOSE: We hypothesized that assessment of myocardial sympathetic activity with no-carrier-added (nca) (123)I-meta-iodobenzylguanidine (MIBG) compared to carrier-added (ca) (123)I-MIBG would lead to an improvement of clinical performance without major differences in radiation dosimetry. METHODS: In...
Autores principales: | Verberne, Hein J., Busemann Sokole, Ellinor, van Moerkerken, Astrid F., Deeterink, Joop H. W. M., Ensing, Geert, Stabin, Michael G., Somsen, G. Aernout, van Eck-Smit, Berthe L. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668584/ https://www.ncbi.nlm.nih.gov/pubmed/18183394 http://dx.doi.org/10.1007/s00259-007-0668-y |
Ejemplares similares
-
Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009) -
Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2012) -
A European myocardial (123)I-mIBG cross-calibration phantom study
por: Verschure, Derk O., et al.
Publicado: (2017) -
Variations in (123)I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation
por: Verberne, Hein J., et al.
Publicado: (2007) -
Vascular time-activity variation in patients undergoing (123)I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
por: Verberne, Hein J., et al.
Publicado: (2011)